STE 📈 STERIS - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: IE00BFY8C754

STE: Cleaning Chemistries, Sterilizers, Endoscope Reprocessing Systems, Medical Devices

STERIS plc is a global leader in infection prevention, providing a comprehensive range of products and services to healthcare providers, pharmaceutical manufacturers, and research institutions worldwide.

The company operates through three distinct segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment is dedicated to providing innovative solutions for sterile processing departments, including cleaning chemistries, sterility assurance products, and automated endoscope reprocessing systems. Additionally, it offers a wide range of capital equipment, such as sterilizers, washers, and surgical tables, as well as equipment management services, including installation, maintenance, and repair.

The AST segment focuses on providing contract sterilization and testing services to medical device and pharmaceutical manufacturers through a network of state-of-the-art facilities. This segment also designs and manufactures integrated sterilization equipment and control systems for medical device manufacturers and research institutions.

The Life Sciences segment specializes in designing, manufacturing, and selling consumable products, including pharmaceutical detergents, cleanroom disinfectants, and sterilants, as well as pharmaceutical-grade sterilizers and washers. This segment also offers equipment installation, maintenance, and repair services, ensuring that customers have access to reliable and efficient solutions.

STERIS plc serves a diverse range of customers, including hospitals, healthcare providers, and pharmaceutical manufacturers, providing them with comprehensive solutions to prevent infections and ensure a safe and healthy environment. With a strong commitment to innovation and customer satisfaction, the company has established itself as a trusted partner in the healthcare industry.

Founded in 1985, STERIS plc is headquartered in Mentor, Ohio, and has a strong online presence at https://www.steris.com.

Additional Sources for STE Stock

STE Stock Overview

Market Cap in USD 21,623m
Sector Healthcare
Industry Medical Devices
GiC Industry Health Care Equipment & Supplies
TER 0.00%
IPO / Inception 1992-06-01

STE Stock Ratings

Growth 5y 46.0%
Fundamental 45.7%
Dividend 52.0%
Rel. Performance Sector -0.34
Analysts 3.89/5
Fair Price Momentum 195.49 USD
Fair Price DCF 178.26 USD

STE Dividends

Dividend Yield 12m 1.01%
Yield on Cost 5y 1.48%
Annual Growth 5y 6.87%
Payout Consistency 96.76%

STE Growth Ratios

Growth Correlation 3m -93%
Growth Correlation 12m 37.7%
Growth Correlation 5y 69.3%
CAGR 5y 8.00%
CAGR/Mean DD 5y 0.75
Sharpe Ratio 12m 0.35
Alpha -20.59
Beta 0.89
Volatility 21.10%
Current Volume 627.9k
Average Volume 20d 737k
What is the price of STE stocks?
As of December 05, 2024, the stock is trading at USD 216.65 with a total of 627,909 shares traded.
Over the past week, the price has changed by +0.27%, over one month by -3.81%, over three months by -10.45% and over the past year by +9.76%.
Is STERIS a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, STERIS (NYSE:STE) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 45.73 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of STE as of December 2024 is 195.49. This means that STE is currently overvalued and has a potential downside of -9.77%.
Is STE a buy, sell or hold?
STERIS has received a consensus analysts rating of 3.89. Therefor, it is recommend to buy STE.
  • Strong Buy: 3
  • Buy: 2
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for STE stock price target?
According to ValueRays Forecast Model, STE STERIS will be worth about 215.3 in December 2025. The stock is currently trading at 216.65. This means that the stock has a potential downside of -0.61%.
Issuer Forecast Upside
Wallstreet Target Price 249.4 15.1%
Analysts Target Price 242 11.7%
ValueRay Target Price 215.3 -0.6%